Bacillus anthracis edema toxin suppresses human macrophage phagocytosis and cytoskeletal remodeling via the protein kinase A and exchange protein activated by cyclic AMP pathways

Infection and Immunity

Volumn 77, Issue 6, 2009, Pages 2530-2543

  Yeager, Linsey A ^a,b   Chopra, Ashok K ^a   Peterson, Johnny W ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPORTER; BACILLUS ANTHRACIS EDEMA TOXIN; BACTERIAL TOXIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; F ACTIN; UNCLASSIFIED DRUG; ANTHRAX TOXIN; BACTERIAL ANTIGEN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAPGEF3 PROTEIN, HUMAN;

AMES TEST; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL VIRULENCE; CELL FUNCTION; CELL SPREADING; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME REPRESSION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOMODULATION; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; BACTERIAL SPORE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOGENICITY;

ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSKELETON; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MACROPHAGES; PHAGOCYTOSIS; SPORES, BACTERIAL;

EID: 66549106225     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00905-08     Document Type: Article

References (63)

1. Abrami, L., M. Fivaz, and F. van der Goot. 2000. Adventures of a pore-forming toxin at the target cell surface. Trends Microbiol. 8:168-172. (Pubitemid 30224752)
2. Abrami, L., N. Reig, and F. van der Goot. 2005. Anthrax toxin: the long and winding road that leads to the kill. Trends Microbiol. 13:72-78. (Pubitemid 40174866)
3. Ahuja, N., P. Kumar, and R. Bhatnagar. 2004. The adenylate cyclase toxins. Crit. Rev. Microbiol. 30:187-196.
4. Akagawa, K. 1994. Differentiation and function of human monocytes. Hum. Cell 7:116-120.
5. Akagawa, K. 2002. Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages. Int. J. Hematol. 76:27-34.
6. Alam, S., M. Gupta, and R. Bhatnagar. 2005. Inhibition of platelet aggregation by anthrax edema toxin. Biochem. Biophy. Res. Commun. 339:107-114.
7. Andressen, R., W. Brugger, C. Scheibenbogen, M. Kreutz, H. Leser, A. Rehm, and G. Lohr. 1990. Surface phenotype analysis of human monocyte to macrophage maturation. J. Leukoc. Biol. 47:490-497.
8. Aronoff, D., C. Canetti, C. Serezani, M. Luo, and M. Peters-Golden. 2005. Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J. Immunol. 174:595-599. (Pubitemid 40094248)
9. Ben Nasr, A., J. Haithcoat, J. Masterson, J. Gunn, T. Eaves-Pyles, and G. Klimpel. 2007. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J. Leukoc. Biol. 80:774-786.
10. Bradley, K., J. Mogridge, M. Mourez, R. Collier, and J. Young. 2001. Identification of the cellular receptor for anthrax toxin. Nature 414:225-229. (Pubitemid 33051239)
11. Bryn, T., M. Mahic, J. Enserink, F. Schwedem, E. Aandahl, and K. Tasken. 2006. The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages. J. Immunol. 176:7361-7370. (Pubitemid 43849037)
12. Cantarow, W., H. Cheung, and G. Sundharads. 1978. Effects of prostaglandins on the spreading, adhesion, and migration of mouse peritoneal macrophages. Prostaglandins 16:39-42. (Pubitemid 8394135)
13. Chakrabarty, K., W. Wu, J. Booth, E. Duggan, K. Coggeshall, and J. Metcalf. 2006. Bacillus anthracis spores stimulate cytokine and chemokine innate immune responses in human alveolar macrophages through multiple mitogen-activated protein kinase pathways. Infect. Immun. 74:4430-4438.
14. Christensen, A., J. Selheim, S. de Rooj, F. Dremier, F. Schwede, K. Dao, A. Martinez, C. Maenhaut, J. Bos, H. Genieser, and S. Doskeland. 2003. cAMP analog mapping of Epac1 and cAMP kinase: discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278:35394-35402.
15. Collins, S. 1987. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70:1233-1244. (Pubitemid 18026122)
16. Comer, J., A. Chopra, J. Peterson, and R. Konig. 2005. Direct inhibition of T-lymphocyte activation of anthrax toxins in vivo. Infect. Immun. 73:8275-8281.
17. Comer, J., C. Galindo, F. Zhang, A. Wenglikowski, K. Bush, H. Garner, J. Peterson, and A. Chopra. 2006. Murine macrophage transcriptional and functional responses to Bacillus anthracis edema toxin. Microb. Pathog. 41:96-110.
18. Cote, C., N. Van Rooijen, and S. Welkos. 2006. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect. Immun. 74:469-480.
19. Crawford, M., C. Aylott, R. Bourdeau, and G. Bokoch. 2006. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J. Immunol. 176:7557-7565.
20. de Rooij, J., F. J. Zwartkruis, M. H. Verheijen, R. H. Cool, S. M. Nijman, A. Wittinghofer, and J. L. Bos. 1998. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474-477. (Pubitemid 28553318)
21. Dixon, T., M. Meselson, J. Guillemin, and P. Hanna. 1999. Anthrax. N. Engl. J. Med. 341:815-826.
22. Drum, C. L., S. Z. Yan, J. Bard, Y. Q. Shen, D. Lu, S. Soelaiman, Z. Grabarek, A. Bohm, and W. J. Tang. 2002. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 415:396-402. (Pubitemid 34100945)
23. Firoved, A., G. Miller, M. Moayeri, R. Kakkar, Y. Shen, J. Wiggins, E. McNally, W. Tang, and S. Leppla. 2005. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 167:1309-1320.
24. Fontana, J., D. Colbert, and A. Deisseroth. 1981. Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell line. Proc. Natl. Acad. Sci. USA 78:3863-3866.
25. Friedlander, A. 1999. Clinical aspects, diagnosis, and treatment of anthrax. J. Appl. Microbiol. 87:303.
26. Reference deleted.
27. Ho, H., R. Rohatgi, A. Lebensohn, L. Ma, J. Li, S. Gygi, and M. Kirschner. 2004. Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex. Cell 118:203-216. (Pubitemid 38962576)
28. Hong, J., R. Doebele, M. Lingen, L. Quilliam, W. Tang, and M. Rosner. 2007. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J. Biol. Chem. 282:19781-19787.
29. Hoover, D., A. Friedlander, L. Rogers, and I. Yoon. 1994. Anthrax edema toxin differentially regulates LPS-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cAMP. Infect. Immun. 62:4432-4439.
30. Howe, A. 2004. Regulation of actin-based cell migration by cAMP/PKA. Biochim. Biophys. Acta 1692:159-174.
31. Howe, A., L. Baldor, and B. Hogan. 2005. Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration. Proc. Natl. Acad. Sci. USA 102:14320-14325.
32. Hu, H., Q. Sa, T. Koehler, A. Aronson, and D. Zhou. 2006. Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell. Microbiol. 8:1634-1642.
33. Hu, T., S. Ramachandra Rao, S. Siva, C. Valancius, Y. Zhu, K. Mahadev, I. Toh, B. Goldstein, M. Woolkalis, and K. Sharma. 2005. Reactive oxygen species production via NADPH oxidase mediates TGF-β-induced cytoskeletal alterations in endothelial cells. Am. J. Physiol. Renal Physiol. 289:F816-F842.
34. Ihara, S., T. Oka, and Y. Fukui. 2006. Direct binding of SWAP-70 to non-muscle actin is required for membrane ruffling. J. Cell Sci. 119:500-507.
35. Kang, T., M. Fenton, M. Weiner, S. Hibbs, S. Basu, L. Baillie, and A. Cross. 2005. Murine macrophages kill the vegetative form of Bacillus anthracis. Infect. Immun. 73:7495-7501.
36. Kassam, A., S. Der, and J. Mogridge. 2005. Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin. Cell. Microbiol. 7:281-292.
37. Katoh, M., and M. Katoh. 2004. Identification and characterization of human FNBP1L gene in silico. Int. J. Mol. Med. 13:157-162.
38. Kawasaki, H., G. M. Springett, N. Mochizuki, S. Toki, M. Nakaya, M. Matsuda, D. E. Housman, and A. M. Graybiel. 1998. A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275-2279. (Pubitemid 29004080)
39. Kirby, J. 2004. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 72:430-439.
40. 2 via their high basal and inducible levels of catalase activity. J. Biol. Chem. 276:24360-24364.
41. Kumar, P., N. Ahuja, and R. Bhatnagar. 2002. Anthrax edema toxin requires influx of calcium for inducing cyclic AMP toxicity in target cells. Infect. Immun. 70:4997-5007.
42. Lasunskaia, E., M. Campos, M. de Andrade, R. Damatta, T. Kipnis, M. Einicker-Lamas, and W. Da Silva. 2006. Mycobacteria directly induce cytoskeletal rearrangements for macrophage spreading and polarization through TLR2-dependent PI3K signaling. J. Leukoc. Biol. 80:1480-1490.
43. Leppla, S. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 79:3162-3166.
44. Leppla, S., and P. Greengard. 1984. Advances in cyclic nucleotide and protein phosphorylation research, p. 189-198. Raven Press, New York, NY.
45. Loughran, G., N. Healy, P. Kiely, M. Huigsloot, N. Kedersha, and R. O'Connor. 2005. Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses anchorage-independent growth. Mol. Biol. Cell 16:1811-1822.
46. Matsuda, S., K. Akagawa, M. Honda, Y. Yokota, Y. Takebe, and T. Takemori. 1995. Suppression of HIV replication in human monocyte-derived macrophages induced by granulocyte/macrophage colony-stimulating factor. AIDS Res. Hum. Retrovir. 11:1031-1038.
47. May, R., and L. Machesky. 2001. Phagocytosis and the actin cytoskeleton. J. Cell Sci. 114:1061-1077. (Pubitemid 32288521)
48. Nakata, K., K. Akagawa, M. Fukayama, Y. Hayashi, M. Kadokura, and T. Tokunaga. 1991. Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro. J. Immunol. 147:1266-1272.
49. Nakata, K., M. Weiden, T. Harkin, D. Ho, and W. Rom. 1995. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1-infected patients: evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Mol. Med. 1:744-757.
50. O'Brien, J., A. Friedlander, T. Dreier, J. Ezzell, and S. Leppla. 1985. Effects of anthrax toxin components on human neutrophils. Infect. Immun. 47:306-310.
51. Paccani, S., F. Tonello, R. Ghittoni, M. Natale, L. Muraro, M. M. D'Elios, W. Tang, C. Montecucco, and C. Balderi. 2005. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J. Exp. Med. 201:325-331.
52. Peterson, J., J. Comer, W. Baze, D. Noffsinger, A. Wenglikowskie, K. Walberg, J. Hardcastle, J. Pawlik, K. Bush, J. Taormina, S. Moen, J. Thomas, B. Chatuev, L. Sower, A. Chopra, L. Stanberry, R. Sawada, W. Scholz, and J. Sircar. 2007. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Infect. Immun. 75:3414-3424.
53. Popov, S., R. Villasmil, J. Bernardi, E. Grene, J. Cardwell, A. Wu, D. Alibek, C. Bailey, and K. Alibek. 2002. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 293:349-355.
54. Preisz, H. 1909. Experimentelle Studien åber Virulenz, Empfänglichkeit und 541 Immunität beim Milzbrand. Z. Immunität. Forsch. 5:341-452.
55. Razin, E., S. Bauminger, and A. Globerson. 1978. Effects of prostaglandins on phagocytosis of sheep erythrocytes by mouse peritoneal macrophages. J. Reticuloendothel. Soc. 23:237-242.
56. Rossi, S., F. Tonello, L. Patrussi, N. Capitani, M. Simonato, C. Montecucco, and C. Baldari. 2007. Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signaling. Cell. Microbiol. 9:924-929.
57. Scobie, H., G. Rainey, K. Bradley, and J. Young. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 100:5170-5174.
58. Shinohara, M., Y. Terada, A. Iwamatsu, A. Shinohara, N. Mochizuki, M. Higuchi, Y. Gotoh, S. Ihara, S. Nagata, H. Itoh, Y. Fukui, and R. Jessberger. 2002. SWAP-70 is a guanine-nucleotide-exchange factor that mediates signaling of membrane ruffling. Nature 416:759-763. (Pubitemid 34429154)
59. Takei, K., K. Tokuyama, M. Kato, and A. Morikawa. 1998. Role of cAMP in reducing superoxide anion generation in guinea pig alveolar macrophages. Pharmacol. 57:1-7.
60. Tang, W., J. Krupinski, and A. Gilman. 1991. Expression and characterization of calmodulin-activated (type 1) adenylylcyclases. J. Biol. Chem. 266:8595-8603.
61. Voth, D., E. Hamm, L. Nguyen, A. Tucker, I. Salles, O. Ortiz-Leduc, and J. Ballard. 2005. Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell. Microbiol. 7:1139-1149.
62. Welkos, S., A. Friedlander, S. Weeks, S. Little, and I. Mendelson. 2002. In vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J. Med. Microbiol. 51:821-831.
63. Wright, G., and G. Mandell. 1986. Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide. J. Exp. Med. 164:1700-1709.